{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-068983","form_type":"8-K","ticker":"SRTS","cik":"0001494891","company_name":"Sensus Healthcare, Inc.","filed_at":"2022-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.847226+00:00","generated_at":"2026-06-22T08:50:31.870377+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sensus Healthcare Q3 revenue $9.0M (+64% YoY), EPS $0.11 vs $0.01; introduces Silk laser system","bullets":["Revenue $9.0M (+64% YoY); net income $1.8M ($0.11 diluted EPS) vs $0.2M ($0.01) a year ago.","Adjusted EBITDA $2.3M vs $0.5M; cash $37.6M, no debt.","Introduced Silk™ laser hair removal system; launched SRT-100 Vision upgrades with new ultrasound.","Shipped first of 10 TDI Systems to Hair Enhancement Centers; shipped 4 SRT units to China.","Expects Q4 growth and full-year profitability; notes Hurricane Ian impact on Florida customers."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-068983","json":"https://secwatch.observer/filing/0001213900-22-068983.json","markdown":"https://secwatch.observer/filing/0001213900-22-068983.md","text":"https://secwatch.observer/filing/0001213900-22-068983.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1494891/000121390022068983/0001213900-22-068983-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1494891/000121390022068983/ea167965-8k_sensushealth.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T08:50:31.870377+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8cb4ffff3afec1ea1c617e651498aff365554748","claim":"Sensus Healthcare, Inc. reported third quarter of 2022 results: revenue $9.0 million, net income $1.8 million, EPS $0.11 per diluted share.","evidence_excerpt":"PRESS RELEASE, DATED NOVEMBER 3, 2022 Exhibit 99.1 Sensus Healthcare Reports Third Quarter 2022 Financial Results Profitability continues with revenues up 64% to $9.0 million, diluted EPS of $0.11 compares with $0.01 a year ago Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (November 3, 2022) – Sensus Healthcare, Inc. (Nasdaq:","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1494891/000121390022068983/0001213900-22-068983-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter of 2022"},{"label":"Revenue","value":"$9.0 million"},{"label":"Net income","value":"$1.8 million"},{"label":"EPS","value":"$0.11 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}